Nanocarriers brain targeting (40 résultats)

Paperback. Etat : New. Brand new book, sourced directly from publisher. Dispatch time is 7-8 days from our warehouse. Book will be sent in robust, secure packaging to ensure it reaches you securely.

Etat : New.

Etat : As New. Unread book in perfect condition.

Etat : New.

Etat : New.

Etat : New.

Etat : As New. Unread book in perfect condition.

Etat : New.

Paperback / softback. Etat : New. New copy - Usually dispatched within 4 working days.

hardcover. Etat : New. Brand new. Slight shelf wear scuffs on cover. Ships from Friends bookstore to benefit Beaverton (Oregon) library.

Etat : New.

Paperback. Etat : Brand New. 534 pages. 9.21x6.14x1.10 inches. In Stock.

Hardcover. Etat : New. Brand new book, sourced directly from publisher. Dispatch time is 6-7 days from our warehouse. Book will be sent in robust, secure packaging to ensure it reaches you securely.

Etat : New.

Taschenbuch. Etat : Neu. Nanocarriers for Brain Targeting | Principles and Applications | Raj K. Keservani (u. a.) | Taschenbuch | Einband - flex.(Paperback) | Englisch | 2022 | Apple Academic Press | EAN 9781774634127 | Verantwortliche Person für die EU: Taylor and Francis, Taylor & Francis Verlag Gmbh, Kaufingerstr 24, 80331 München, gpsr[at]taylorandfrancis[dot]com | Anbieter: preigu.…

Etat : New.

Etat : As New. Unread book in perfect condition.

Hardcover. Etat : new. Hardcover. This new volume, Nanocarriers for Brain Targeting: Principles and Applications, covers recent research on brain physiology and the development of drug delivery systems. It explores a diverse variety of strategies that can be employed to achieve drug targeting to the brain. The nanocarriers that are discussed include nanoparticles, vesicular carriers, carriers having carbon as a core constituent, dispersed systems, and more. The inherent anatomy and physiology of the brain renders it different from other organs. The past few decades have witnessed significant research on brain ailments in response to a majority of hospitalizations that occur due to age-related central nervous system disorders. The prevalence of diverse diseases such as Alzheimers disease, Parkinsons disease, amyotrophic lateral sclerosis, multiple sclerosis, HIV-dementia, etc., affect about 1.5 billion people globally, which is further anticipated to reach 1.9 billion by the year 2020. Nanocarriers for drug delivery to the brain are seen as one of the answers to this growing problem. This new volume covers recent research on brain physiology and the development of drug delivery systems, exploring a diverse variety of strategies that can be employed to achieve drug targeting to the brain. The authors discuss nanoparticles, vesicular carriers, carriers having carbon as a core constituent, dispersed systems, and more. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.…

Etat : As New. Unread book in perfect condition.

Etat : New.

Hardback. Etat : New. New copy - Usually dispatched within 4 working days.

Etat : New.

Hardcover. Etat : Brand New. 593 pages. 9.50x6.50x1.25 inches. In Stock.

Etat : New. Raj K. Keservani, MPharm, is a faculty of pharmaceutics at Sagar Institute of Research and Technology-Pharmacy, Bhopal, India. He has more than seven years of academic (teaching) experience from various institutes of India in pharmaceutical educat.

Etat : New.

Buch. Etat : Neu. Neuware.

Hardcover. Etat : new. Hardcover. This new volume, Nanocarriers for Brain Targeting: Principles and Applications, covers recent research on brain physiology and the development of drug delivery systems. It explores a diverse variety of strategies that can be employed to achieve drug targeting to the brain. The nanocarriers that are discussed include nanoparticles, vesicular carriers, carriers having carbon as a core constituent, dispersed systems, and more. The inherent anatomy and physiology of the brain renders it different from other organs. The past few decades have witnessed significant research on brain ailments in response to a majority of hospitalizations that occur due to age-related central nervous system disorders. The prevalence of diverse diseases such as Alzheimers disease, Parkinsons disease, amyotrophic lateral sclerosis, multiple sclerosis, HIV-dementia, etc., affect about 1.5 billion people globally, which is further anticipated to reach 1.9 billion by the year 2020. Nanocarriers for drug delivery to the brain are seen as one of the answers to this growing problem. This new volume covers recent research on brain physiology and the development of drug delivery systems, exploring a diverse variety of strategies that can be employed to achieve drug targeting to the brain. The authors discuss nanoparticles, vesicular carriers, carriers having carbon as a core constituent, dispersed systems, and more. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.…

hardcover. Etat : New. NEW. SHIPS FROM MULTIPLE LOCATIONS. book.

Etat : As New. Unread book in perfect condition.

Etat : As New. Unread book in perfect condition.